Update on Recall of Bayer Kogenate FS from National Organizations
Patient organizations are in ongoing communication with manufacturer
Update on Recall of Bayer Kogenate FS from National Organizations Read More »
Medical Advisory
National Joint Statement on Recall of Bayer Kogenate FS Lots
Last week, Bayer announced the recall of two lots of Kogenate® FS antihemophilic factor (recombinant) 2000 IU vials. That highly concerning announcement has raised many questions on the part of both national organizations and community members.
National Joint Statement on Recall of Bayer Kogenate FS Lots Read More »
Medical Advisory: Bayer Announces Recall of Two Lots of Kogenate FS
July 19, 2019 Bayer has announced a recall of two lots of Kogenate® FS 2000 IU vials.
Medical Advisory: Bayer Announces Recall of Two Lots of Kogenate FS Read More »
CSL Behring Discontinues Production and Distribution of Monoclate-P®
If you are currently using Monoclate-P®, please contact your physician or hemophilia treatment center to learn about other options that are available to you for treatment.
CSL Behring Discontinues Production and Distribution of Monoclate-P® Read More »
Genentech Issues Statement on Hemlibra
If you have questions or concerns, please reach out to Genentech and/or your physician.
Genentech Issues Statement on Hemlibra Read More »
Alnylam Suspends Fitusiran Dosing due to Thrombotic Event
The Company has suspended dosing in all ongoing fitusiran studies pending further review of the safety event and development of a risk mitigation strategy.
Alnylam Suspends Fitusiran Dosing due to Thrombotic Event Read More »
